F. Lesaunier

Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial

C. Carrié, Ali Hasbini, Guy de Laroche et al. · The Lancet Oncology · 2016 · 361 citations

Medicine, Oncology, Urology +15

Is There a Role for Pelvic Irradiation in Localized Prostate Adenocarcinoma? Preliminary Results of GETUG-01

P. Pommier, Sylvie Chabaud, J. L. Lagrange et al. · Journal of Clinical Oncology · 2007 · 343 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial

Karim Fizazi, Laura Faivre, F. Lesaunier et al. · The Lancet Oncology · 2015 · 238 citations

Medicine, Oncology, Urology +17

Phase III Randomized Trial of Very Accelerated Radiation Therapy Compared With Conventional Radiation Therapy in Squamous Cell Head and Neck Cancer: A GORTEC Trial

Jean Bourhis, M. Lapeyre, J. Tortochaux et al. · Journal of Clinical Oncology · 2006 · 152 citations · Full text

Medicine, Oncology, Radiation Oncology +6

Health-related quality of life and sequelae in patients treated with brachytherapy and external beam irradiation for localized prostate cancer

F. Joly, D. Brune, J.E. Couette et al. · Annals of Oncology · 1998 · 101 citations · Full text

Medicine, Radiation Oncology, Urology +16